Deadline on April 9th coming up in Lawsuit for Investors who lost money with Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) shares

A deadline is coming up on April 9, 2024 in the lawsuit filed for certain investors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX).

Investors who purchased shares of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) have certain options and there are strict and short deadlines running. Deadline: April 9, 2024. NASDAQ: AMLX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges on behalf of purchasers of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) common shares between November 11, 2022 and November 8, 2023, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between November 11, 2022 and November 8, 2023, the Defendants made false and/or misleading statements and/or failed to disclose that the Defendants had overstated RELYVRIO's commercial prospects, that patients were discontinuing treatment with RELYVRIO after six months, that the rate at which new patients were starting treatment with RELYVRIO was decreasing, that accordingly, that the Defendants had also overstated RELYVRIO's prescription rate, that the Defendants attempted to hide the foregoing negative trends from investors and the market by blocking analysts from viewing RELYVRIO's prescription data, and that as a result, the Defendants' public statements were materially false and misleading at all relevant times.

Those who purchased shares of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.